Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF – Get Free Report)’s share price rose 2.9% during trading on Monday . The company traded as high as $9.36 and last traded at $9.36. Approximately 500 shares traded hands during mid-day trading, a decline of 17% from the average daily volume of 600 shares. The stock had previously closed at $9.10.
Newron Pharmaceuticals Trading Up 2.9 %
The company’s 50-day simple moving average is $9.31 and its 200 day simple moving average is $10.27.
About Newron Pharmaceuticals
Newron Pharmaceuticals S.p.A., a biopharmaceutical company, focus on the development of novel therapies for the treatment of central nervous system (CNS) and pain in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, Switzerland, the United Kingdom, the United States of America, Australia, Canada, Latin America, Israel, the United Arab Emirates, Japan, and South Korea.
Read More
- Five stocks we like better than Newron Pharmaceuticals
- Trading Halts Explained
- Intel: Is Now the Time to Be Brave?
- 3 Warren Buffett Stocks to Buy Now
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Short Selling: How to Short a Stock
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Newron Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Newron Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
